In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Factor VIII/IX claims will not be pursued by federal insurers, according to DoJ/defendants agreement.

Executive Summary

FACTOR VIII/IX CLAIMS BY FEDERAL INSURERS WILL NOT BE PURSUED, according to an April 30 letter from the defendants in the hemophilia/HIV class action suit to Chicago federal court Judge John Grady. The Department of Justice, which represented federal insurance programs, is accepting the payment of the $640 mil. settlement to hemophilia patients who received HIV-tainted blood ("The Pink Sheet" March 24, p. 11). The government insurers, which may have paid for some of the treatments, will not seek to recover money from the settlements.
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030131

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel